Abstract
A major backlog has developed in handling complaints over drug companies’ marketing practices in the UK. Hristio Boytchev, Shai Mulinari, and Piotr Ozieranski report
Original language | English |
---|---|
Article number | q365 |
Journal | BMJ (Clinical research ed.) |
Volume | 384 |
DOIs |
|
Publication status | Published - 14 Feb 2024 |